Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Blockbuster Q3 Earnings – Sales Beat and Outlook Raised Levi Strauss & Co. delivered strong third-quarter 2025 results, topping estimates and defying retail sector headwinds. Revenue for Q3 (June–August 2025) hit $1.54 billion, up 7% year-on-year and slightly above analyst expectations of ~$1.50 billion reuters.com tipranks.com. Adjusted
New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

Latest Developments & October Stock Surge After a quiet summer, New Era Energy & Digital’s stock exploded in early October 2025 on the back of major project news and aggressive investor outreach. On October 9, NUAI shares nearly doubled intraday – a one-day
USA Rare Earth Stock Skyrockets on Rare Earth Boom and White House Buzz – What’s Driving USAR’s Record High?

USA Rare Earth (USAR) Stock Soars on Rare Earth Boom and White House Buzz – What Investors Need to Know

Company Background & Operations USA Rare Earth, Inc. is a U.S.-based critical minerals company focused on establishing a fully domestic rare-earth supply chain – from mining and processing raw rare earth elements to manufacturing finished rare-earth magnets. The company’s flagship asset is the Round Top
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reports ts2.tech ts2.tech fiercebiotech.com; MarketBeat and DirectorsTalk analyst surveys marketbeat.com directorstalkinterviews.com; Economic Times deal summary economictimes.indiatimes.com economictimes.indiatimes.com; Business Wire legal alert businesswire.com businesswire.com; and TradingView market data marketbeat.com tradingview.com.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing stockanalysis.com. Turn’s
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Forecast: Experts believe that within the next 2–3 years, we’ll know if Novo’s gamble pays off. Phase 3 readouts for efruxifermin are anticipated in 2026, and Novo hopes to launch the drug by late this decade if approved reuters.com. By then, the landscape
PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

Key Data & Metrics (as of October 9, 2025) Metric Value Stock Price (Oct 8, 2025) $138.84 (close) marketbeat.comDown ~6% in past month; ~–6% YTD finviz.com indexbox.io 52-Week Range Low $127.60 – High $177.48 markets.businessinsider.com Market Capitalization ~$193 Billion markets.businessinsider.com
Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Deutsche Börse AG: Structure, Divisions & Subsidiaries Deutsche Börse AG is the backbone of Germany’s capital markets infrastructure. Founded in 1992 as a joint-stock company, it has grown into a multinational marketplace organizer for securities trading and related services en.wikipedia.org.
1 246 247 248 249 250 434
Go toTop